NCT05381129

Brief Summary

The aim of this clinical study to evaluate the effect of temporomandibular joint dysfunction accompanying patients with chronic migraine on pain, quality of life, sleep and functionality.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2022

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 10, 2022

Completed
4 days until next milestone

First Submitted

Initial submission to the registry

May 14, 2022

Completed
5 days until next milestone

First Posted

Study publicly available on registry

May 19, 2022

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 20, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

November 20, 2022

Completed
Last Updated

September 28, 2023

Status Verified

September 1, 2023

Enrollment Period

6 months

First QC Date

May 14, 2022

Last Update Submit

September 26, 2023

Conditions

Outcome Measures

Primary Outcomes (6)

  • Allodynia

    The patients will be evaluated for allodynia with the Allodynia Symptom Checklist. The Allodynia Symptom Checklist include 12 questions about the frequency of various allodynia symptoms in association with headache attacks. Instead of using a dichotomous option (yes or no), the response categories are "never," "rarely," "less than half the time," and "half the time or more." In addition, subjects can also indicate that an item "does not apply to me." That option is used by someone who never shaved their face or someone who never wore a ponytail.

    7 days

  • Health-Related Quality

    The patients will be evaluated for the quality of life with The Short Form-36. This form is composed of 36 items and eight subscales to evaluate quality of life (physical functioning, role-physical, bodily pain, general health, vitality, social functioning, role-emotional, and mental health). The scores of the subscales range between 0 and 100, and higher scores indicate higher quality of life.

    7 days

  • Headache-related disability

    The patients will be evaluated for headache-related disability with The Migraine Disability Assessment Test. Migraine Disability Assessment scores (numerical scores represent number of days patients missed or lost productivity at work or school, as well as missed days from family/social/leisure activities, and range from little or no disability (0-5) to severe disability (\>20).

    3 months

  • The impact of headache on quality of life

    The patients will be evaluated for the impact of headache on quality of life with 6-item short-form Headache Impact Test. This test is a patient-reported outcome measure used to measure the impact and effect of headache on the ability to function normally in daily life. It consists of 6 questions, total scores may range from 36 to 78 and higher scores reflecting greater impact.

    3 months

  • Sleep quality

    The patients will be evaluated for sleep quality with the Pittsburgh Sleep Quality Index. It contains 19 self-reported items and 5 items to be completed by a bed partner or roommate, if possible. Scores range from 0 to 3, and are summed to obtain a global score, which ranges from 0 to 21. Higher scores indicate greater sleep disturbance.

    7 days

  • Temporomandibular dysfunction

    The patients will be evaluated for temporomandibular dysfunction with Helkimo Clinical Dysfunction Index. This index include the following signs: impaired range of movement of the mandible, impaired function of the joint, pain with movement of the mandible, muscle pain, and joint pain. Patients are given a score of 0 points for absence of symptoms, 1 point for mild pain or dysfunction, and 5 points for severe pain or dysfunction.

    7 days

Secondary Outcomes (1)

  • Descriptive information

    3 days

Study Arms (2)

Chronic migraine

OTHER

Patients diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3).

Other: Detection of Pain, Quality of Life, Sleep and Functioning

Temporomandibular dysfunction

OTHER

Patients diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3), and patients with temporomandibular dysfunction.

Other: Detection of Pain, Quality of Life, Sleep and FunctioningOther: Temporomandibular joint dysfunction

Interventions

All patients will be evaluated for allodynia, quality of life, headache-related disability, and sleep quality.

Chronic migraineTemporomandibular dysfunction

Patients with jaw complaints will be evaluated for temporomandibular joint dysfunction.

Temporomandibular dysfunction

Eligibility Criteria

Age18 Years - 50 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64)

You may qualify if:

  • For patients with chronic migraine:
  • Being diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3)
  • Being literate
  • For patients with temporomandibular dysfunction :
  • Diagnosed with chronic migraine according to the International Headache Society Classification (ICHD-3)
  • Being literate
  • Pain in the temporomandibular joint region and chewing muscles for at least 3 months, limitation in mouth opening, noise from the joint when opening the mouth, and / or having complaints and findings such as non-harmonic jaw movements
  • Getting a score of ≥1 according to the Helkimo Clinical Craniomandibular Dysfunction Index

You may not qualify if:

  • For patients with chronic migraine:
  • Complaint of chronic pain in another part of their body other than the head and face region
  • Having another pathology that can explain their pain in the head and face region other than chronic migraine (such as sinusitis, tension-type headache, trigeminal neuralgia, drug overuse headache)
  • Psychiatric disease or using psychiatric drugs
  • History of serious head trauma or neurosurgical intervention
  • Those with a history of infectious, chronic inflammatory disease, malignancy
  • Pregnant and breastfeeding women
  • History of additional neurological disease other than migraine
  • Uncooperative
  • Having congestive heart failure, chronic kidney failure, chronic liver disease, lung disease, uncontrolled diabetes, peripheral vascular disease
  • Presence of trauma or operation in the temporomandibular joint
  • History of facial paralysis
  • Actively receiving treatment related to the temporomandibular joint

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Istanbul University- Cerrahpasa

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

HeadacheTemporomandibular Joint DisordersChronic Pain

Interventions

Quality of LifeSleepFunctional Status

Condition Hierarchy (Ancestors)

PainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and SymptomsCraniomandibular DisordersMandibular DiseasesJaw DiseasesMusculoskeletal DiseasesJoint DiseasesMuscular DiseasesStomatognathic Diseases

Intervention Hierarchy (Ancestors)

Health StatusDemographyEpidemiologic MeasurementsPublic HealthEnvironment and Public HealthNervous System Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaActivities of Daily LivingRehabilitationHealth ServicesHealth Care Facilities Workforce and Services

Study Officials

  • Uğur Uygunoğlu, MD

    Istanbul University - Cerrahpasa

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NON RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

May 14, 2022

First Posted

May 19, 2022

Study Start

May 10, 2022

Primary Completion

November 20, 2022

Study Completion

November 20, 2022

Last Updated

September 28, 2023

Record last verified: 2023-09

Data Sharing

IPD Sharing
Will not share

Locations